DFTX · Categories · Coverage
DFTX - Analyst coverage initiated
Definium Therapeutics Inc. (DFTX) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for DFTX
- Wells Fargo initiated coverage on Definium Therapeutics with a new price targetWells Fargo initiated coverage of Definium Therapeutics with a rating of Overweight and set a new price target of $68.00
- Stifel initiated coverage on Definium Therapeutics with a new price targetStifel initiated coverage of Definium Therapeutics with a rating of Buy and set a new price target of $30.00
- Piper Sandler initiated coverage on Definium Therapeutics with a new price targetPiper Sandler initiated coverage of Definium Therapeutics with a rating of Overweight and set a new price target of $49.00
- Wolfe Research initiated coverage on Definium Therapeutics with a new price targetWolfe Research initiated coverage of Definium Therapeutics with a rating of Outperform and set a new price target of $25.00
- Jefferies initiated coverage on Definium Therapeutics with a new price targetJefferies initiated coverage of Definium Therapeutics with a rating of Buy and set a new price target of $30.00